| 000 | 00815 a2200205 4500 | ||
|---|---|---|---|
| 005 | 20250514052117.0 | ||
| 264 | 0 | _c20021120 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a1362-0347 | ||
| 024 | 7 |
_a10.1136/ebmh.5.4.113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarois, Marie-Josée | |
| 245 | 0 | 0 |
_aHaloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia. _h[electronic resource] |
| 260 |
_bEvidence-based mental health _cNov 2002 |
||
| 300 |
_a113 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 700 | 1 | _aRoy, Marc-André | |
| 773 | 0 |
_tEvidence-based mental health _gvol. 5 _gno. 4 _gp. 113 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ebmh.5.4.113 _zAvailable from publisher's website |
| 999 |
_c12247123 _d12247123 |
||